esterified estrogens
Selected indexed studies
- Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy. (Menopause, 2025) [PMID:40742784]
- [Equine estrogens vs. esterified estrogens in the climacteric and menopause. The controversy arrives in Mexico]. (Gac Med Mex, 2001) [PMID:11432092]
- Lipoprotein-associated estrogens. (Cardiovasc Res, 2002) [PMID:12393088]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. (2004) pubmed
- Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy. (2025) pubmed
- [Equine estrogens vs. esterified estrogens in the climacteric and menopause. The controversy arrives in Mexico]. (2001) pubmed
- Lipoprotein-associated estrogens. (2002) pubmed
- Estratest and Estratest HS (esterified estrogens and methyltestosterone) therapy: a summary of safety surveillance data, January 1989 to August 2002. (2003) pubmed
- Esterified estrogens combined with methyltestosterone raise intraocular pressure in postmenopausal women. (2006) pubmed
- Therapeutic interchange of conjugated and esterified estrogens in a managed care organization. (1999) pubmed
- Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. (2001) pubmed
- Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women. (2000) pubmed
- A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women. (1993) pubmed